Transcelerate Biopharma Inc
Transcelerate Biopharma Inc's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $1,104,805 for Janice Chang, Ceo (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $1,133,875. It is higher than the D + F figure for 22 of 22 peer organizations selected under the disclosed tier Same NTEE major group (H), nationwide + size band 0.77–1.3× revenue (approximately 100%; median $398,089). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Transcelerate Biopharma Inc, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.77–1.3× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| The Colorado Prevention Center | CO | $39,223,624 | $364,988 |
| Nsabp Foundation Inc | PA | $37,602,507 | $61,579 |
| The Foundation Fighting Blindness Inc | MD | $36,615,169 | $555,661 |
| Bliss Cares Inc | FL | $36,602,971 | $216,937 |
| American Urological Association | MD | $35,937,186 | $576,451 |
| Conquer Cancer Foundation Of The | VA | $41,435,619 | $46,782 |
| Centre County Cancer Center | PA | $35,447,002 | $207,437 |
| Critical Path Institute | AZ | $42,610,862 | $456,980 |
View the organization record and available filings on ProPublica